GLP-1 weight loss medications used by public figures for metabolic health

Public figures in South Korea and the United States are utilizing GLP-1 receptor agonist injections to manage weight and metabolic health.

South Korean comedian Yoo Min-sang recently disclosed on the MBN program ‘Sokpuri Show Dongchimi’ that he has begun a medically supervised weight loss regimen. This decision followed a clinical warning regarding his body mass index (BMI) and metabolic profile, which highlighted long-term morbidity risks. GLP-1 agonists work by mimicking hormones to regulate glycemic control and suppress appetite by targeting the hypothalamus.

In the United States, actress Chrissy Metz reported losing 100 pounds through the use of a GLP-1 medication. Metz stated during an interview on ‘The Today Show’ that her decision was driven by the need to prioritize her health and address concerns related to aging. Her weight loss has sparked debate regarding the body positivity movement and the social implications of medical weight management.